2012•Zhongguo fuyou baojianRequires access

Analysis on levonorgestrel-releasing intrauterine system for prevention of tamoxifen-induced endometrial polyp among the patients with breast cancer

Qing Zheng

Open publisher page 0 citations

Abstract

Objective:To explore the effect of levonorgestrel-releasing intrauterine system(LNG-IUS) for prevention of tamoxifen-induced endometrial polyp among the patients with breast cancer.Methods:One hundred and three women who took tamoxifen during perimenopausal period and menopausal period were randomly divided into two groups.Fifty-five women underwent Mirena insertion before taking tamoxifen,and the other forty-eight women were selected as control group.Before treatment and at twelve months after treatment of tamoxifen,transvaginal ultrasound was used to measure the depth of endometrium,and hysteroscope was used for pathological examination of endometrium.Results:The risk of endometrial polyp in Mirena group was significantly lower than that in control group(1.8%∶ 15.5%,P=0.02).There was no significant difference in the risk of submucosal fibroid between the two groups(1.8%∶ 3.4%,P=1.0).Conclusion:LNG-IUS can reduce the occurrence of tamoxifen-induced endometrial polyp among the patients with breast cancer.

About this research paper

What this paper is about

Objective:To explore the effect of levonorgestrel-releasing intrauterine system(LNG-IUS) for prevention of tamoxifen-induced endometrial polyp among the patients with breast cancer.Methods:One hundred and three women who took tamoxifen during perimenopausal period and menopausal period were randomly divided into two groups.Fifty-five women underwent Mirena insertion before taking tamoxifen,and the other forty-eight women were selected as control group.Before treatment and at twelve months after treatment of tamoxifen,transvaginal ultrasound was used to measure the depth of endometrium,and hysteroscope was used for pathological examination of endometrium.Results:The risk of endometrial polyp in Mirena group was significantly lower than that in control group(1.8%∶ 15.5%,P=0.02).There was no significant difference in the risk of submucosal fibroid between the two groups(1.8%∶ 3.4%,P=1.0).Conclusion:LNG-IUS can reduce the occurrence of tamoxifen-induced endometrial polyp among the patients with breast cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To explore the effect of levonorgestrel-releasing intrauterine system(LNG-IUS) for prevention of tamoxifen-induced endometrial polyp among the patients with breast cancer.Methods:One hundred and three women who took tamoxifen during perimenopausal period and menopausal period were randomly divided into two groups.Fifty-five women underwent Mirena insertion before taking tamoxifen,and the other forty-eight women were selected as control group.Before treatment and at twelve months after treatment of tamoxifen,transvaginal ultrasound was used to measure the depth of endometrium,and hysteroscope was used for pathological examination of endometrium.Results:The risk of endometrial polyp in Mirena group was significantly lower than that in control group(1.8%∶ 15.5%,P=0.02).There was no significant difference in the risk of submucosal fibroid between the two groups(1.8%∶ 3.4%,P=1.0).Conclusion:LNG-IUS can reduce the occurrence of tamoxifen-induced endometrial polyp among the patients with breast cancer.

Key concepts: Medicine, Endometrial Polyp, Tamoxifen, Levonorgestrel, Endometrium, Breast cancer, Gynecology, Endometrial cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis on levonorgestrel-releasing intrauterine system for prevention of tamoxifen-induced endometrial polyp among the patients with breast cancer — Research Paper | ScholarLens